AMENDMENT No. 7 to MULTI-PRODUCT LICENCE AGREEMENT datedMulti-Product Licence Agreement • March 15th, 2021 • NGM Biopharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2021 Company IndustryTHIS AMENDMENT No. 7 (“Amendment No.7”) to the Multi-Product Licence Agreement, dated 31 October 2014, as amended by Amendment No. 1, dated 28 July 2015, Amendment No. 2, dated 07 October 2015, Amendment No. 3, dated 26 April 2016, Amendment No. 4, dated 03 October 2017, Amendment No. 5, dated 16 March 2018, and Amendment No. 6, dated 06 February 2019 (collectively the “Agreement”) is made effective as of the last dates of signatures between the parties (the “Amendment No. 7 Effective Date”).